Results 11 to 20 of about 19,645 (252)

GM1 and GM2 gangliosides: recent developments

open access: yesBiomolecular Concepts, 2014
GM1 and GM2 gangliosides are important components of the cell membrane and play an integral role in cell signaling and metabolism. In this conceptual overview, we discuss recent developments in our understanding of the basic biological functions of GM1 ...
Bisel Blaine   +2 more
doaj   +6 more sources

Identification of GM1-Ganglioside Secondary Accumulation in Fibroblasts from Neuropathic Gaucher Patients and Effect of a Trivalent Trihydroxypiperidine Iminosugar Compound on Its Storage Reduction [PDF]

open access: yesMolecules
Gaucher disease (GD) is a rare genetic metabolic disorder characterized by a dysfunction of the lysosomal glycoside hydrolase glucocerebrosidase (GCase) due to mutations in the gene GBA1, leading to the cellular accumulation of glucosylceramide (GlcCer).
Costanza Ceni   +10 more
doaj   +2 more sources

Interaction between Simian Virus 40 Major Capsid Protein VP1 and Cell Surface Ganglioside GM1 Triggers Vacuole Formation [PDF]

open access: goldmBio, 2016
Simian virus 40 (SV40), a polyomavirus that has served as an important model to understand many aspects of biology, induces dramatic cytoplasmic vacuolization late during productive infection of monkey host cells.
Yong Luo   +5 more
doaj   +2 more sources

Ganglioside GM1 and the Central Nervous System [PDF]

open access: goldInternational Journal of Molecular Sciences, 2023
GM1 is one of the major glycosphingolipids (GSLs) on the cell surface in the central nervous system (CNS). Its expression level, distribution pattern, and lipid composition are dependent upon cell and tissue type, developmental stage, and disease state, which suggests a potentially broad spectrum of functions of GM1 in various neurological and ...
Zhongwu Guo
openalex   +3 more sources

Trial of ganglioside GM1 in acute stroke. [PDF]

open access: bronzeJournal of Neurology, Neurosurgery & Psychiatry, 1989
On the whole, these data indicate a possible effectiveness ofGMI in the treatment of stroke. We think that the real efficacy of the drug will be demonstrated not only by a larger study, but also through more selective criteria regarding the stroke (ischaemic or haemorrhagic) and the time of therapy (beginning and duration).
Ildebrando Appollonio   +2 more
openalex   +3 more sources

Home - About - Disclaimer - Privacy